Tower Research Capital LLC (Trc) Phathom Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $3.53 Billion
  • Q2 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,710 shares of PHAT stock, worth $77,427. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,710
Previous 3,608 58.26%
Holding current value
$77,427
Previous $22,000 145.45%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$2.29 - $10.9 $4,813 - $22,911
2,102 Added 58.26%
5,710 $54,000
Q1 2025

May 15, 2025
SELL
$4.22 - $7.74 $3,401 - $6,238
-806 Reduced 18.26%
3,608 $22,000
Q4 2024

Feb 13, 2025
BUY
$7.45 - $18.94 $201 - $511
27 Added 0.62%
4,414 $35,000
Q3 2024

Nov 14, 2024
SELL
$10.25 - $19.5 $14,616 - $27,807
-1,426 Reduced 24.53%
4,387 $79,000
Q2 2024

Aug 13, 2024
BUY
$8.97 - $12.05 $46,940 - $63,057
5,233 Added 902.24%
5,813 $59,000
Q1 2024

May 15, 2024
SELL
$6.21 - $11.05 $57,635 - $102,555
-9,281 Reduced 94.12%
580 $6,000
Q4 2023

Feb 13, 2024
BUY
$6.99 - $10.71 $3,844 - $5,890
550 Added 5.91%
9,861 $90,000
Q3 2023

Nov 14, 2023
BUY
$10.26 - $15.7 $90,636 - $138,693
8,834 Added 1851.99%
9,311 $96,000
Q2 2023

Aug 14, 2023
SELL
$7.28 - $14.32 $8,939 - $17,584
-1,228 Reduced 72.02%
477 $6,000
Q1 2023

May 09, 2023
BUY
$6.19 - $12.36 $7,545 - $15,066
1,219 Added 250.82%
1,705 $12,000
Q4 2022

Feb 10, 2023
SELL
$9.18 - $11.53 $36,398 - $45,716
-3,965 Reduced 89.08%
486 $5,000
Q3 2022

Nov 10, 2022
SELL
$6.46 - $12.11 $6,001 - $11,250
-929 Reduced 17.27%
4,451 $49,000
Q2 2022

Aug 15, 2022
BUY
$6.2 - $15.5 $10,440 - $26,102
1,684 Added 45.56%
5,380 $45,000
Q1 2022

May 12, 2022
BUY
$11.55 - $20.06 $37,884 - $65,796
3,280 Added 788.46%
3,696 $51,000
Q4 2021

Feb 14, 2022
SELL
$17.83 - $33.15 $3,387 - $6,298
-190 Reduced 31.35%
416 $8,000
Q3 2021

Nov 15, 2021
SELL
$30.69 - $36.83 $99,036 - $118,850
-3,227 Reduced 84.19%
606 $19,000
Q2 2021

Aug 16, 2021
BUY
$32.66 - $39.87 $82,205 - $100,352
2,517 Added 191.26%
3,833 $130,000
Q1 2021

May 17, 2021
SELL
$33.86 - $48.68 $28,476 - $40,939
-841 Reduced 38.99%
1,316 $49,000
Q4 2020

Feb 16, 2021
SELL
$33.22 - $50.26 $300,807 - $455,104
-9,055 Reduced 80.76%
2,157 $72,000
Q3 2020

Nov 16, 2020
BUY
$29.24 - $40.19 $264,855 - $364,041
9,058 Added 420.52%
11,212 $411,000
Q2 2020

Aug 13, 2020
BUY
$25.06 - $54.6 $53,979 - $117,608
2,154 New
2,154 $71,000

Others Institutions Holding PHAT

# of Institutions
137
Shares Held
60.5M
Call Options Held
1.35M
Put Options Held
1.19M
View Full List

About Phathom Pharmaceuticals, Inc.

PHAT Quotes by TradingView
  • Ticker PHAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,175,200
  • Market Cap $531M
  • Description
  • Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...
More about PHAT
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email